Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/01/25
End: 10/01/28
Due: 10/01/29
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 11/24/24
Due: 11/24/25
Phase: N/A
Priority: Normal
Start: 10/31/16
End: 10/31/22
Due: 10/31/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST | NCT06735820 | AeRang Kim | user2@example.com | None | 2025-04-01 | 2028-10-01 | 2029-10-01 | - | - | 2025-07-14 |
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors | NCT02076906 | AeRang Kim | user2@example.com | None | 2014-04-30 | 2024-11-24 | 2025-11-24 | - | - | 2025-07-14 |
| A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors | NCT02536183 | AeRang Kim | user2@example.com | None | 2016-10-31 | 2022-10-31 | 2023-10-31 | - | - | 2025-07-14 |